Report Publication Announcement • Jun 2, 2015
Report Publication Announcement
Open in ViewerOpens in native device viewer
Longjumeau, 2 June 2015: PCAS (Euronext Paris: PCA), expert in the development and production of complex molecules for Life Sciences and Innovative Technologies, today announced its financial calendar for the second part of 2015 and the beginning of 2016.
The timetable is indicative only and is subject to change.
The timetable is also available on the PCAS website, under the heading "Investors".
PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €166 million in 2014 and employs nearly 900 people in six countries. To find out more about PCAS, visit www.pcas.com.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.